Segments - Percutaneous Nephrostomy Catheters Market by Tube Type (Malecot, Pigtail, Balloon Retention, and Others), Application (Urinary Tract Obstruction, Percutaneous Nephrolithotomy, Antegrade Pyelography, and Others), Material (Silicone, Polyethylene, Polyurethane, and Others), End-user (Hospitals & Ambulance Surgery Centers, Specialty Clinics, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The Global Percutaneous Nephrostomy Catheters Market size was valued at USD 398 Million in 2022 and is expected to surpass USD 782.44 Million by 2031, expanding at a CAGR of 7.8% during the forecast period, 2023 – 2031. The market growth is attributed to the rising prevalence of kidney ailments, supportive government policies, and an increase in awareness about kidney diseases.
A percutaneous nephrostomy catheter is used to remove kidney stones artificially by using a rubber tube called a catheter. The removal is done by placing a catheter through the flank or back of the patient into the kidney to drain urine with stones.
The kidneys are responsible for balancing mineral, water, and salt levels in the body. Excessive and unwanted amounts of minerals are passed through urine as waste. When urine contains a disproportionate amount of waste, crystals begin to form obstructing the flow of the urine and affecting the filtration process of the kidneys.
Kidney stones can be formed for a variety of reasons including congenital conditions, dehydration, a high-protein high-calcium diet, and obesity. The surgeries related to digestive diseases and a high incidence of urinary tract infections also affect kidney functioning. The kidney stones are removed safely by using percutaneous nephrostomy catheters. This method has a success ratio of approximately 75% to 98% in urinary tract infection therapeutics.
The human anatomy is designed in such a way that it shows early symptoms of health problems including kidney diseases. Kidney diseases are likely to reach end-stage if not diagnosed and treated within the specified time. Policymakers are encouraging health professionals to improve rates of early diagnosis and treatment of kidney diseases.
According to ScienceDirect, globally almost 10% of people are affected by kidney stone complications in the course of their lives. This number is likely to grow because of changes in dietary patterns, the growing aging population, and the consumption of supplementary food by the masses.
Health professionals are spreading awareness among the general population about the importance of early treatment of kidney diseases to avoid life-threatening conditions. The ongoing amendments in the surgery practices for both the surgeon and the patient can pave way for the market growth in the future.
The market report finds that the COVID-19 pandemic has elevated market growth as awareness about early diagnosis and treatment of health issues has been highlighted in the general population. This trend of early diagnosis and treatment continues to elevate the growth of the market significantly.
The market report has up-to-date insights that help formulate a strategic roadmap about the estimated market scenario and performance from 2023 to 2031.
High acceptance of percutaneous nephrostomy catheters among clinicians and patients for removing stones is one of the major trends driving the market growth. The patients prefer a treatment that has a high level of efficacy and better recovery rates.
Percutaneous nephrostomy catheters provide a safe and efficient method of removing stones by minimizing the side effects and maximizing the clinical outcome. This phenomenon is giving a boost to a trend of rising acceptance of catheters in clinical procedures for removing kidney stones in the coming years.
Unhealthy dietary patterns and their effects on kidney functions are likely to drive market growth significantly in the years to come. People are knowingly or unknowingly consuming unhealthy food packed with significantly high amounts of calcium and protein in a fast-paced environment.
Balanced food and the right amount of hydration are often neglected during working hours. This gigantic shift in daily life has caused many health issues including kidney complications.
A significant rise in the aging population is one of the major factors driving the growth of the market. The prevalence of urological diseases such as hydronephrosis, prostate cancer, and bladder obstruction is relatively higher in the geriatric population. This factor drives the market growth significantly.
The stringent code of surgery practices outlined by the regulators can hamper the growth of the market. Policymakers are putting up efforts to amend the code of conduct for surgeons to avoid any adversity during and after surgery. Adherence to a code of conduct by surgeons while conducting surgery could be a major hindrance to market growth.
The technological advancements in minimally invasive surgical devices and the willingness of patients to undergo nephrostomy can create substantial growth opportunities in the market.
The market participants are collaborating with each other to develop advanced catheters for conducting minimally invasive methods of kidney stone removal techniques. Advanced catheters with minimal side effects can serve as the best option for high-risk patients.
The report on the global percutaneous nephrostomy catheters market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Percutaneous Nephrostomy Catheters Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2020 – 2021 |
Forecast Period |
2023–2031 |
Segmentation |
Tube Type (Malecot, Pigtail, Balloon Retention, and Others), Application (Urinary Tract Obstruction, Percutaneous Nephrolithotomy, Antegrade Pyelography, and Others), Material (Silicone, Polyethylene, Polyurethane, and Others), and End-user (Hospitals & Ambulance Surgery Centers, Specialty Clinics, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
BD; Boston Scientific Corporation; Cook; Coloplast Corp.; UROMED Kurt Drews KG; Bentec Medical OpCo LLC; Amecath; and Teleflex Incorporated. |
Based on the tube type segment, the percutaneous nephrostomy catheters market is divided into malecot, pigtail, balloon retention, and others.
The malecot segment is widely used because of its feasibility and convenience in draining stones through urine. The modified versions of malecot catheters provide ease of performing drainage of the stones by accessing the inner parts of the pelvis of the kidney.
The pigtail catheters segment is expected to expand at a significant growth rate during the projection period, owing to their effectiveness and safety during nephrostomy. Pigtail catheters are correctly positioned to avoid catheter dislodgement during nephrostomy drainage providing relief to the patient.
In terms of application, the market is segmented into urinary tract obstruction, percutaneous nephrolithotomy, antegrade pyelography, and others.
The percutaneous nephrolithotomy segment is projected to hold major revenue shares in the market, owing to its usage in urinary tract obstruction remedies as it provides improved safety and reliability during the drainage of kidney stones.
On the basis of material, the market is segmented into silicone, polyethylene, polyurethane, and others.
The silicone segment is anticipated to hold a key share of the market, as silicone is relatively soft, hypoallergenic, and tissue friendly compared to its counterparts. Silicone-based catheters provide relief to the patient during the drainage of the stones.
Based on the end-user segment, the market is segregated into hospitals & ambulance surgery centers, specialty clinics, and others.
The hospitals & ambulance surgery centers segment is projected to register a considerable CAGR during the forecast period on the account of the convenience of availing percutaneous nephrostomy surgeries and supportive policies of the government. The patients prefer the hospitals for all-inclusive packages. The growth of the segment is further attributed to the availability of support staff and post-surgery care offered at the hospitals.
In terms of region, the global percutaneous nephrostomy catheters market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
North America is expected to dominate the market during the projection period owing to the high acceptance of percutaneous nephrostomy and technological advancements in the percutaneous nephrostomy catheter designs to provide comfort and relief to patients. The presence of a majority of key players in the region also makes it easy for patients to access the latest healthcare devices and modules.
Asia Pacific is projected to grow at a rapid pace in the percutaneous nephrostomy catheters market, owing to a rising aging population, health reimbursement programs, and improved healthcare infrastructure in the region.
The governments in emerging economies of the region such as India and China are focused to provide healthcare services to the people by strategically locating healthcare centers for convenience. Improving access to healthcare services is likely to boost the percutaneous nephrostomy catheters market growth in Asia Pacific in the coming years.
The global percutaneous nephrostomy catheters market has been segmented on the basis of
Key players competing in the global percutaneous nephrostomy catheters market are BD; Boston Scientific Corporation; Cook; Coloplast Corp.; UROMED Kurt Drews KG; Bentec Medical OpCo LLC; Amecath; and Teleflex Incorporated.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. The competitive landscape covers key insights into growth strategies adopted by major market players.
In April 2021, Becton Dickinson and Company (BD) announced that it received premarket clearance from the U.S. Food and Drug Administration for Pristine, the new hemodialysis catheter useful for treating patients with end-stage kidney diseases.